The Latest Breaking News from FDA

The Food and Drug Administration has said it was following the latest approved safety information when it extended the shelf life of some batches of Pfizer Covid-19 vaccine to 15 months from nine.

Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….

The U.S. Food and Drug Administration (FDA) has warned against using an eye drop made in India that has been linked to the outbreak of a drug-resistant bacteria leading to adverse events in at least 55 patients in the United States including infections, blindness and one death.

ORLANDO, Fla. — In the days after the 2016 Pulse gay nightclub shooting ―the second-deadliest mass shooting in U.S. history — gay and bisexual men were turned away from donating blood unless they had been celibate for a year.

A college student's fight to get coverage exposed the insurer’s hidden procedures for rejecting claims

More than a dozen attorneys general sent a threatening letter to the chains, citing a law from 1873

WASHINGTON — The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.

Medication abortion, which accounts for more than half of all abortions in the United States, has become more common since the Supreme Court overturned the federal right to abortion this summer.

The public health emergency created an array of health flexibilities, impacting everything from Medicaid to telehealth coverage.